Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs—A Comparison of Methods
Cells · 2024
DOI: 10.3390/cells13121016 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cells, 2024. Verfasst von Kirstin O McDonald und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Brain Health Research Centre and Genetics Otago, University of Otago, Dunedin 9016, New Zealand. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Induced Pluripotent Stem Cells, Cell Differentiation, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Neurological Foundation of New Zealand.
Abstract (Originalsprache)
Dopaminergic neurons are the predominant brain cells affected in Parkinson’s disease. With the limited availability of live human brain dopaminergic neurons to study pathological mechanisms of Parkinson’s disease, dopaminergic neurons have been generated from human-skin-cell-derived induced pluripotent stem cells. Originally, induced pluripotent stem-cell-derived dopaminergic neurons were generated using small molecules. These neurons took more than two months to mature. However, the transcription-factor-mediated differentiation of induced pluripotent stem cells has revealed quicker and cheaper methods to generate dopaminergic neurons. In this study, we compared and contrasted three protocols to generate induced pluripotent stem-cell-derived dopaminergic neurons using transcription-factor-mediated directed differentiation. We deviated from the established protocols using lentivirus transduction to stably integrate different transcription factors into the AAVS1 safe harbour locus of induced pluripotent stem cells. We used different media compositions to generate more than 90% of neurons in the culture, out of which more than 85% of the neurons were dopaminergic neurons within three weeks. Therefore, from our comparative study, we reveal that a combination of transcription factors along with small molecule treatment may be required to generate a pure population of human dopaminergic neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Brain Health Research Centre and Genetics Otago, University of Otago, Dunedin 9016, New Zealand.
ORCID-Profile: Stephanie M Hughes, Indranil Basak
Förderung
- Neurological Foundation of New Zealand
Zitieren
APA
McDonald, K. O., Lyons, N. M. A., Gray, L. K. C., Xu, J. B., Schoderboeck, L., Hughes, S. M., & Basak, I. (2024). Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs—A Comparison of Methods. Cells. https://doi.org/10.3390/cells13121016
Vancouver
McDonald KO, Lyons NMA, Gray LKC, Xu JB, Schoderboeck L, Hughes SM, et al. Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs—A Comparison of Methods. Cells. 2024. doi:10.3390/cells13121016
BibTeX
@article{McDonald2024,
author = {McDonald, Kirstin O and Lyons, Nikita M A and Gray, Luca K C and Xu, Janet B and Schoderboeck, Lucia and Hughes, Stephanie M and Basak, Indranil},
title = {Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs—A Comparison of Methods},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13121016}
}
EUVIMED